ニュース

STAT7 時間Opinion
Following second patient death, Duchenne muscular dystrophy families deserve answers about ...
Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...
Parent Project Muscular Dystrophy Hosts 2025 Annual Conference in Las Vegas, Nevada
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), will host its 2025 Annual Conference in Las Vegas, Nevada, June ...
InnovationRx: The Dangers Of RFK Jr.’s Vaccine Advisory Committee
In this week’s edition of InnovationRx, we look at the dangers of RFK Jr.’s vaccine advisory committee, how Trump’s visa ban ...
MarketBeat on MSN11 時間
Sarepta Drops 42% on Fatalities; Markets Eye Solid Biosciences
In another tragic incident, Sarepta Therapeutics (NASDAQ: SRPT) saw a second death in connection with its Duchenne muscular ...
Roku upgraded, Sarepta downgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research ...
BioSpace17 時間
Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics
Another patient has died from acute liver failure after receiving Sarepta’s gene therapy for DMD ; After a quiet start to the ...
Sarepta: TD Cowen downgrades rating, cuts PT on FDA pullback risk for Elevidys
Investing.com-- TD Cowen downgraded its rating on Sarepta Therapeutics Inc (NASDAQ: SRPT) and slashed its price target ...